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Abstract
Background. The etiology of nephrocalcinosis is variable.
In this study, we wanted to elucidate whether the histopa-
thological appearance of calcium phosphate deposits
provides information about possible etiology.
Methods. Autopsy cases from the years 1988 to 2007 and
native kidney biopsies from a 50-year period (1959–2008)
with nephrocalcinosis were identified. The biopsy cases
were re-evaluated by light microscopy. The autopsy cases
were analysed according to the underlying disease. The bi-
opsy cases were grouped with respect to the likely etiology
of nephrocalcinosis. Total number, density, localization,
size and pattern of all calcification foci were documented
and correlated with clinical and laboratory data.
Results. About 223 of 12 960 autopsy cases (1.7%) had
nephrocalcinosis, 111 of which (49.8%) suffered from ad-
vanced malignant tumours. Nephrocalcinosis was the main
diagnosis in 48 of 12 480 native kidney biopsies (0.4%).
Clinicopathological correlation revealed a specific pattern
of calcification associated with hyperphosphataemia and/or
hyperphosphaturia: these cases showed predominant glob-
ular or shell-like calcifications (phosphate type). In con-
trast, the biopsies of the hypercalcaemic/hypercalciuric
group had a different predominant pattern with clumpy or
finely granular calcifications (calcium type).
Conclusions. Our results indicate that hyperphosphaturia-
associated cases of nephrocalcinosis can be distinguished
from hypercalciuria-associated cases histopathologically.
Keywords: colonoscopy; histopathology; hypercalciuria;
hyperphosphaturia; nephrocalcinosis
Introduction
Nephrocalcinosis is a clinical term defined as the renal
deposition of calcium. This definition includes deposits of
different chemical composition, such as calcium oxalate or
calcium phosphate, and can, but does not have to be associ-
ated with nephrolithiasis. Pathologists distinguish between
oxalosis and nephrocalcinosis, the latter again covering dif-
ferent compositions but excluding calcium oxalate. Tradi-
tionally, pathologists used the term ‘calcium nephrosis’ for
dystrophic calcification i.e. calcification of necrosis and the
term ‘nephrocalcinosis’ for metastatic calcification [1]. In our
study, we defined nephrocalcinosis as metastatic renal calci-
fications (excluding oxalosis) by histopathological detection
of calcium deposits without associated tissue necrosis.
Nephrocalcinosis can be classified according to the local-
ization of the deposits: calcium can precipitate predomi-
nantly in the medulla, as for example in the medullary
sponge kidney. Calcifications mainly located in the renal
cortex are found, for example, in cortical necrosis. In con-
trast to ultrasonography or computed tomography, light mi-
croscopy can further distinguish whether calcifications are
localized in the tubular lumens, tubular epithelium, tubular
basement membrane or in interstitial space [2]. On the other
hand, nephrocalcinosis can be classified according to the
chemical composition, which is likely associated with the
etiology of renal calcification. Typically, calcium precipi-
tates with anions in the kidney forming calcium oxalate or
calcium phosphate (as hydroxyl apatite) deposits.
Renal calcium deposits occur (i) in disorders associated
with impaired homeostasis and an increased renal excretion
of calcium or phosphate or (ii) by an altered solubility, e.g.
due to a locally altered pH value in the course of renal
tubular acidosis, hypocitraturia or tissue necrosis. Apart
from that, factors facilitating crystal adhesion to the tubular
epithelium seem to be a prerequisite for nephrocalcinosis
[3–5]. Hypercalciuria can occur with hypercalcaemia (see
Table 1, e.g. in primary hyperparathyroidism, elevated vi-
tamin D3, sarcoidosis) or with normal serum calcium levels
(idiopathic hypercalciuria). In analogy, hyperphosphaturia
can be associated with hyperphosphataemia or with normal
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or low serum phosphate levels due to impaired reabsorption
in the tubules.
Elevated levels of calcium as well as elevated levels of
phosphate can lead to calcium phosphate deposits, which
can be visualized histochemically by the von Kossa stain.
Hyperphosphataemia can be caused by oral sodium phos-
phate bowel purgative intake, leading to renal calcium
phosphate deposition, also referred to as acute phosphate
nephropathy [6–8]. Hyperphosphataemia has also been re-
ported in children suffering from nephrotic syndrome [9].
The aim of this study was (i) to determine the fre-
quency of nephrocalcinosis (excluding oxalosis and
dystrophic calcification of necrosis) in autopsies and re-
nal biopsies and (ii) to elucidate whether the etiology of
nephrocalcinosis was associated with a special morpho-
logical pattern, including appearance, distribution and
density of calcifications. A correlation would indicate that
the histological examination of calcification patterns
could help to determine the possible mechanism and
etiology of nephrocalcinosis in a given case, which is
Table 1. Clinicopathological data of 48 biopsy cases with nephrocalcinosisa
Gender
(M/F)
Age
(years) Disease/condition
Calcification
type (Ca/P)
Calcification
foci (number)
Clumpy
(%)
Granular
(%)
Globular
(%)
Shell-
like (%)
Onion
skin (%)
Hypercalciuria M 52 Lung cancer Ca 10 10.0 60.0 10.0 20.0 0.0
M 3 Lymphoblastic leukemia Ca 5 40.0 60.0 0.0 0.0 0.0
M 25 Sarcoidosis Ca 15 13.3 66.7 20.0 0.0 0.0
M 51 Sarcoidosis Ca 19 15.8 36.8 31.6 10.5 5.3
M 49 Sarcoidosis Ca 5 40.0 60.0 0.0 0.0 0.0
F 65 Hyperparathyreoidism Ca 6 16.7 83.3 0.0 0.0 0.0
F 34 Hyperparathyreoidism Ca 12 25.0 66.7 8.3 0.0 0.0
M 43 Paracellin 1 mutation Ca 5 60.0 40.0 0.0 0.0 0.0
M 13 Dent’s disease Ca 4 0.0 100.0 0.0 0.0 0.0
Hyperphosphaturia F 62 Phosphate purgatives P 11 0.0 0.0 9.1 72.7 18.2
M 75 Phosphate purgatives P 27 3.7 14.8 29.6 40.7 11.1
F 67 Phosphate purgatives P 3 0.0 0.0 66.7 33.3 0.0
F 69 Phosphate purgatives P 29 0.0 0.0 37.9 62.1 0.0
F 78 Phosphate purgatives P 18 11.1 11.1 27.8 50.0 0.0
F 49 Phosphate diabetes P 9 22.2 11.1 44.4 22.2 0.0
M 10 Nephrotic syndrome Ca/P 6 0.0 50.0 50.0 0.0 0.0
F 2 Nephrotic syndrome P 23 0.0 26.1 34.8 39.1 0.0
M 1 Nephrotic syndrome P 8 12.5 25.0 12.5 50.0 0.0
Unknown cause F 69 Unknown Ca 13 0.0 53.8 7.7 23.1 15.4
M 23 Unknown P 9 33.3 0.0 22.2 44.4 0.0
M 46 Unknown Ca 1 100.0 0.0 0.0 0.0 0.0
F 42 Unknown P 3 33.3 0.0 66.7 0.0 0.0
M Unknown Ca 149 73.8 26.2 0.0 0.0 0.0
F 2 Unknown Ca 36 61.1 33.3 0.0 2.8 2.8
M 18 Unknown Ca 5 80.0 20.0 0.0 0.0 0.0
M 37 Unknown P 15 13.3 6.7 13.3 66.7 0.0
F 44 Unknown P 11 18.2 27.3 18.2 36.4 0.0
F 69 Unknown P 29 6.9 0.0 17.2 75.9 0.0
F 39 Unknown P 9 11.1 22.2 0.0 66.7 0.0
M 29 Unknown Ca 22 63.6 27.3 4.5 0.0 4.5
F 50 Unknown Ca 3 33.3 33.3 33.3 0.0 0.0
F 30 Unknown P 9 0.0 44.4 22.2 33.3 0.0
F 51 Unknown Ca/P 4 50.0 0.0 0.0 50.0 0.0
F 61 Unknown P 21 0.0 23.8 47.6 28.6 0.0
F 69 Unknown Ca 10 20.0 50.0 0.0 30.0 0.0
F 53 Unknown P 9 22.2 11.1 66.7 0.0 0.0
F Unknown P 8 0.0 25.0 0.0 75.0 0.0
M Unknown P 7 28.6 14.3 0.0 57.1 0.0
M 40 Unknown Ca 3 100.0 0.0 0.0 0.0 0.0
M 9 Unknown P 33 9.1 33.3 24.2 33.3 0.0
F 32 Unknown Ca/P 4 0.0 50.0 50.0 0.0 0.0
M 62 Unknown Ca 5 60.0 0.0 40.0 0.0 0.0
M 42 Unknown Ca 8 37.5 25.0 0.0 37.5 0.0
F 66 Unknown Ca 8 62.5 0.0 0.0 37.5 0.0
M 78 Unknown Ca 7 71.4 0.0 28.6 0.0 0.0
F 69 Unknown Ca 4 25.0 75.0 0.0 0.0 0.0
M 36 Unknown Ca 41 12.2 46.3 17.1 24.4 0.0
M 73 Unknown P 11 9.1 0.0 63.6 27.3 0.0
aOverview of the findings in all 48 biopsy cases: column 4 shows the classification of the respective cases into ‘Ca’ (calcium type), if the percentage of
clumpy plus finely granular calcifications is>50% and ‘P’ (phosphate type) and if the percentage of globular plus shell-like calcifications is>50%. Three
cases could not be classified (Ca/P) because they showed 50% calcium type and 50% phosphate type patterns. Column 5 shows the total number of
calcification foci found in the biopsy. Columns 6–10 show the respective frequency of the five different calcification patterns.
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important in biopsy cases if nephrocalcinosis is an
incidental finding.
Materials and methods
Patients and specimens
Frequency. The frequency of nephrocalcinosis was determined in
autopsy cases of the years 1988–2007 (n ¼ 12 960) and in biopsies of
native kidneys of the years 1959–2008 (n ¼ 12 480).
Morphology. All biopsies with the leading histopathological diagnosis
nephrocalcinosis of the years 1959–2008 were included in this study. All
available information, such as age, sex, clinical history, symptoms and labo-
ratory parameters was documented. Histological slides of the undecalcified
formalin (4%) fixed, paraffin-embedded biopsies were systematically ana-
lysed in haematoxylin and eosin (H&E) and periodic acid Schiff (PAS) stains
as well as von Kossa and Alizarin stains for visualization of calcium phos-
phate depositions. Immunohistochemical staining of Tamm-Horsfall protein
(Anti-human Tamm-Horsfall Protein monoclonal antibody clone 10.32; Ce-
darlane laboratories Ltd, Ontario, Canada. Dilution 1:16000) was performed
on paraffin sections of selected cases with sufficient shell-like calcification.
Quantitative and semiquantitative evaluation
Firstly, the biopsy area on the slide (square millimeters) was measured and
the proportion of renal cortex and medulla (%) was assessed in order to
calculate the respective density of calcifications. The density was defined
as the number of calcification foci per square millimeters of the biopsy and
calculated by dividing the total number of calcification foci found in the
biopsy by the total area of the biopsy measured on the slide (foci per square
millimeters). The total number of glomeruli and number of obsolescent
glomeruli were determined and the percentage of the total area with tubular
atrophy and interstitial fibrosis was estimated. The total number of calci-
fication foci were counted and documented with respect to the following
features: localization (cortex, medulla), compartment (tubular lumen, tub-
ular epithelium, tubular basement membrane, interstitium or glomerulus),
size (smaller than a tubular cell, as large as a single cell, larger than a cell,
larger than a tubular cross section) and structure. The morphological pat-
terns of calcification were analysed in detail. The results were expressed as
percent of all calcification foci in the individual biopsy.
Energy-filtered electron microscopy
In order to further characterize the composition of the shell-like calcifications
observed in the phosphate type of nephrocalcinosis, energy-filtered electron
microscopy was performed. This technique, described in detail elsewhere
[10], provides high-resolution imaging with specific element detection and
localization [11]. Shell-like calcifications were examined using this method
in order to determine the chemical composition, particularly the presence of
calcium, phosphor and oxygen within the optically empty centres.
Statistical analysis
Statistical analysis was done with Prism 5 (GraphPad Software, Inc, La
Jolla, CA) using the non-parametric Mann–Whitney test. The morpholog-
ical and clinical parameters were correlated with each other using
Pearson’s correlation coefficient.
Results
Frequency
In 223 of 12 960 (1.7%) autopsy cases from the years 1988
to 2007, nephrocalcinosis was a noteworthy finding.
Around 111 of the patients (49.8%) had advanced malig-
nant tumours (Figure 1A), in only two of the others, the
etiology could be determined; one patient suffered from
sarcoidosis and one from primary hyperparathyroidism.
In 48 of 12 480 native renal biopsy cases (0.4%), neph-
rocalcinosis was a leading diagnosis (Table 1). In the last
of 10 five-year periods (2004–2008), there was an in-
crease in the number of biopsies with nephrocalcinosis
(19 cases), compared to the earlier 5-year periods (0–8
cases, Figure 1B). As illustrated in Figure 1B, about half
of the cases showed the calcium type and the other half
showed the phosphate type of calcification (see below).
Morphology
Five different patterns of calcifications could be distin-
guished: clumpy, finely granular, globular, shell-like and
onion skin-like (see Figure 2). The overall frequencies (of
total 742 calcifications) of the different patterns were 30.1%
clumpy, 30.1% finely granular, 15.8% globular, 22.8%
shell-like and 1.3% onion skin-like. H&E stain proved to
be the best for the differentiation of the calcification patterns.
Neither von Kossa stain nor Alizarin stain allowed the differ-
entiation of the different patterns of calcification.
Median age of the patients (n ¼ 48) was 44.9 years
(1–74.8 years) and half of the patients were females
(24 of 48). Mean serum creatinine was 218 (19–800)
lmol/L, mean serum calcium 2.55 (2.0–4.1) mmol/L and
mean serum phosphate was 1.31 (0.9–3.1) mmol/L.
The biopsies contained 0 to 97 (median 15) glomeruli. The
percentage of globally obsolescent glomeruli ranged from 0
to 75% (median 11%). Tubular atrophy and interstitial fibrosis
varied from 0 to 95% (median 10%). The density of calcifi-
cation foci ranged from 0.01 to 14.9 foci per square milli-
meters (average 1.65/mm2), 0 to 36.7 foci/mm2 in the cortex
and 0 to 5.6 foci/mm2 in the medulla. In 32 biopsies contain-
ing renal cortex and medulla, it was possible to evaluate the
predominant location of nephrocalcinosis. In 18 of these 32
cases (56%), the calcification density was higher in the me-
dulla and in 14 cases (44%), the density was higher in the
cortex. The number of calcification foci adjusted according to
the mean biopsy area (15.4/mm2) was 25.4 foci on average.
Total calcification density did not correlate significantly
with serum creatinine levels [correlation coefficient r ¼
0.37 (P ¼ 0.1904, 95% CI 0.20–0.75)] nor with calcium
3phosphate product [r ¼ 0.27 (P ¼ 0.28, 95% CI 0.23–
0.65)]. No significant correlation was found between serum
calcium and serum creatinine [r ¼ 0.18 (P ¼ 0.3987, 95%
CI 0.24–0.54)]. However, there was a significant
correlation between serum phosphate and serum creatinine
[r ¼ 0.84 (P ¼ 0.0001, 95% CI 0.57–0.94)] and between
the calcium 3phosphate product and serum creatinine [r¼
0.88 (P < 0.0001, 95% CI 0.67–0.96)].
The likely etiology of nephrocalcinosis in our biopsy
cases could be identified in 18 of 48 cases: malignant tu-
mours (n ¼ 2; one acute lymphoblastic leukemia and one
metastatic lung cancer), sarcoidosis (n¼ 3), primary hyper-
parathyroidism (n ¼ 2), paracellin 1 mutation (n ¼ 1),
Dent’s disease (n ¼ 1), intake of sodium phosphate bowel
purgatives before colonoscopy (n¼ 5), children with neph-
rotic syndrome (n ¼ 3) and phosphate diabetes (n ¼ 1). In
the remaining cases, the etiology remained unclear even
after careful re-evaluation of the clinical records (Table 1).
These 18 cases with known etiology were then divided
into two major groups according to the likely mechanism:
(i) diseases and conditions associated with hypercalcaemia
and/or hypercalciuria (malignant tumours, sarcoidosis,
hyperparathyroidism, paracellin 1 mutation, Dent’s dis-
ease) defined as the ‘calcium group’ and (ii) diseases and
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conditions associated with hyperphosphataemia and/or hy-
perphosphaturia (sodium phosphate bowel purgatives,
nephrotic syndrome in children and phosphate diabetes)
defined as the ‘phosphate group’. All three children with
nephrotic syndrome had normal serum calcium levels and
no other reason for nephrocalcinosis could be identified in
the clinical records. Thus, since hyperphosphaturia can oc-
cur in children with nephrotic syndrome [9], we classified
these cases as members of the phosphate group. In regard to
the predominant morphological patterns of the calcium and
phosphate group, a striking difference could be observed.
In the calcium group, the clumpy and the finely granular
Fig. 1. Frequency of nephrocalcinosis. (A) Autopsy cases: 111 of 223 (49.7%) cases of nephrocalcinosis were associated with malignant tumours.
Twenty-five of them had haematological neoplasia, followed by lung (19 cases) and breast (17 cases) cancer, most of which had bone metastases. (B)
Frequency of nephrocalcinosis in native kidney biopsies over the years. Note: there was a clear increase in the last 5 years (19 cases in 2004–2008). About
half of the cases showed a calcium type and the other half a phosphate type calcification pattern. In three cases, the calcification type could not be assigned
to the calcium or phosphate type since half of the calcifications within the respective biopsies showed calcium type patterns and half showed phosphate
type patterns.
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patterns predominated. In contrast, in the phosphate group,
the most frequent pattern was the shell-like calcification,
followed by the globular pattern. Patterns 1–4 reached stat-
istical significance, when the frequencies in the two major
disease groups were compared (Figure 2): Patterns 1 and 2
(clumpy and finely granular) were significantly (P ¼
0.0133 and P¼ 0.0007) more frequent in the calcium group
of diseases, whereas Patterns 3 and 4 (globular and shell-
like) were significantly (P ¼ 0.0032 and P ¼ 0.0014) more
frequent in the phosphate group of conditions. The differ-
ences of Pattern 5 (onion skin-like) were not statistically
significant, this may have been due to its very low overall
occurrence rate. Regarding these results, Patterns 1 and 2
were combined and defined as the ‘calcium type’ (1 1 2)
and Patterns 3 and 4 as the ‘phosphate type’ (3 1 4) of
nephrocalcinosis. These grouped patterns again showed
significant differences between both major groups using
the Mann–Whitney test (Figure 2).
In order to assess how specific the phosphate type of
calcification was for the intake of sodium phosphate pur-
gatives, we performed a blinded test with a subgroup of 12
cases: PAS-stained slides from four patients with phos-
phate nephropathy after colonoscopy and eight patients
from the other defined classes (tumor, hyperparathyroid-
ism, paracellin 1 mutation, nephrotic syndrome and phos-
phate diabetes). The blinded set was shown to two
experienced nephropathologists (H.H. and M.M.), who
were asked to identify the cases of phosphate nephropathy
after colonoscopy by using two given criteria: (i) predom-
inance of cortical calcifications and (ii) predominance of
Fig. 2. Histopathological patterns of nephrocalcinosis. (A) Five different histopathological patterns (H&E 3400, scale bars 20 lm) and (B) schematic
illustration: Column 1, clumpy pattern with homogenous calcifications; column 2, finely granular pattern; column 3, globular pattern with small hollow
spherules; column 4, shell-like pattern with thin outer calcifications surrounding empty cores and column 5, onion skin-like pattern with multilayered
calcifications. (C) The group of ‘hypercalciuria’ showed predominant calcification patterns 1 and 2 (clumpy and finely granular). In contrast, cases of
‘hyperphosphaturia’ had a predominance of patterns 3 and 4 (globular and shell-like). Only very few onion skin-like calcifications were found. (D) After
combining patterns 11 2 and 31 4, significant differences could be observed: patterns 11 2 were associated with conditions leading to hypercalciuria
(calcium type) (P ¼ 0.0003), whereas patterns 3 1 4 were associated with conditions leading to hyperphosphaturia (phosphate type) (P ¼ 0.0004).
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spheroidal or globular intratubular or interstitial clear de-
posits with shell-like calcifications. In the blinded test for
the identification of colonoscopy cases, one of four cases
was not classified as a colonoscopy case by one of the two
pathologists and one case with nephrotic syndrome was
wrongly classified as a colonoscopy case by both patholo-
gists. The overall sensitivity according to the question
‘which cases belong to the colonoscopy group?’ was
87.5% and the specificity was 77.8%. If the question had
been ‘which cases belong to the phosphate group?’ the
sensitivity would have been 90% and the specificity even
100%, because the nephrotic syndrome was also classified
as a hyperphosphaturic condition in our study.
In regard to all cases, including those with unknown
etiology, we found that 24 cases (50%) of all 48 biopsies
with nephrocalcinosis had a predominant calcium type of
calcifications. Twenty-one cases (44%) showed a predom-
inance of the phosphate type, although in most of the cases
a likely underlying condition leading to nephrocalcinosis
could not be determined retrospectively. In three cases
(6%), we could not determine the calcification type, since
half of the foci were of the calcium and the other half of the
phosphate type, respectively (Figure 1B).
In order to further characterize the shell-like calcifica-
tions, additional techniques were applied. Von Kossa and
Alizarin stain demonstrated the presence of phosphate and
calcium within the shell-like calcifications, respectively.
Immunohistochemically, Tamm-Horsfall protein could be
shown in the shells of the deposits (Figure 3). Energy-
filtered electron microscopy revealed calcium, phosphor
and oxygen molecules as main components within the
shells of the phosphate-type calcifications (Figure 4). In
contrast to our assumption that the optically empty centres
of these calcifications might predominantly consist of phos-
phate, we could not detect phosphor and oxygen within the
centers but only in the shells.
No clear differences of the localization or sizes of cal-
cification foci were seen between both major groups. In
cases of acute phosphate nephropathy after colonoscopy,
however, most of the calcifications were intratubular and
located in the renal cortex. Apart from the different calci-
fication patterns of hypercalciuria and hyperphosphaturia,
cases of sarcoidosis could be distinguished from other
subtypes of calcium type nephrocalcinosis by the presence
of epithelioid granulomatous reactions, adjacent to the
calcifications.
Discussion
The overall frequency of nephrocalcinosis, defined as renal
deposition of calcium-containing molecules (excluding cal-
cium oxalate), observed in autopsies and in native renal
biopsies is low (autopsies 1.7%, biopsies 0.4%) but has
increased in the last 5 years. One reason could be an in-
creased number of patients receiving sodium phosphate
solutions for bowel cleansing before colonoscopy [12].
However, this seems not to be the only cause since not
only the phosphate type of nephrocalcinosis, which is typ-
ical for phosphate nephropathy, but the calcium type as
well has been observed more frequently in the last 5 years.
Malignant tumours were identified in only 2 of 48 cases
(4.2%) in our biopsy study. In contrast, in the autopsy
study, in 111 (49.8%) cases advanced malignant tumours
were found. This discrepancy can be explained by the fact
that most of the tumour patients do not undergo renal bi-
opsy because they do not suffer from renal insufficiency or
renal insufficiency is not the leading problem that has to be
clarified by renal biopsy. The most likely reasons for
malignancy-associated nephrocalcinosis are the presence
of bone metastases (osteolytic type) or, probably less
frequently, production of PTH related peptides (humoral
type) by the tumour cells [13].
The main result of our study is the observation that two
different major types of renal calcification can be distin-
guished simply by light microscopy. The two patterns that
characterize the calcium type show finely granular or
clumpy deposits. This type is associated with malignant
tumours, hyperparathyroidism, sarcoidosis, Dent’s disease
or paracellin-1 mutations. The phosphate type, in contrast,
is defined by the presence of shell-like or globular deposits
and probably consists of a phosphate rich core, which may
be associated with several other molecules, surrounded by a
thin layer of calcium phosphate, Tamm-Horsfall protein,
and perhaps other substances. However, energy-filtered
electron microscopy could only reveal the presence of cal-
cium, phosphor and oxygen in the shells but not within the
optically empty centres. Thus, we cannot identify the
chemical composition of the cores of these calcifications
and we cannot exclude washing out of the material in the
centers during the fixation process. This phosphate type in
our study is associated with intake of sodium phosphate
solutions, nephrotic syndrome in children or phosphate
diabetes (Table 2).
The two different patterns likely reflect different mech-
anisms of crystal formation; the calcium type could be
composed predominantly of calcium hydroxyl apatites
[14]. In contrast, the shell-like formations of the phosphate
type seem to be quite similar to a self-organizing phenom-
enon forming concentric-lamellated structures called
Liesegang rings. This similarity is especially apparent in
the electron microscopic appearance of the deposits. The
process of Liesegang phenomenon is thought to involve
diffusion, nucleation, flocculation or precipitation and
supersaturation. Liesegang-like rings have also been de-
scribed in cysts or in fibrotic, inflamed or necrotic tissue
of kidney, synovium, conjunctiva and eyelid [15, 16].
It is well known that nephrocalcinosis also occurs in
renal allografts. Likely reasons are hyperparathyroidism
[17], drug toxicity, as described for calcineurin inhibitors
[18, 19] and hyperphosphaturia due to denervation [20].
Our observation can also be applied to nephrocalcinosis
in renal allograft biopsies to distinguish hyperphosphaturic
from hypercalciuric forms. The phosphate type could be
associated with calcineurin inhibitors since for example,
FK506 (tacrolimus) can lead to increased excretion of
phosphate [21], whereas the calcium type could rather be
associated with hyperparathyroidism (Table 2). However,
whether this is really true and helpful to determine the
likely cause has to be elucidated in further studies. Early
nephrocalcinosis in the renal allograft is sometimes asso-
ciated with hyperparathyroidism and is correlated with
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inferior outcome compared to renal allografts without
calcifications [22]. However, in paediatric patients, renal
allograft calcification seems to be neither correlated with
hypercalciuria nor with a negative influence on graft
function [23].
Calcifications in patients who received sodium phos-
phate solutions seemed to be localized predominantly in
the renal cortex. In some patients with other causes of
nephrocalcinosis, including calcium types, there was, how-
ever, also predominant cortical calcification and, moreover,
Fig. 3. Characteristics of the shell-like calcifications in the phosphate type of nephrocalcinosis after intake of sodium phosphate bowel purgatives before
colonoscopy: (A) Shell-like calcifications (H&E,3400, scale bar 20 lm). (B) Immunohistochemical staining for Tamm-Horsfall protein shows positivity
in the shells of the calcification foci (3200, scale bar 50 lm). (C) Von Kossa reaction visualizes deposition of anions (phosphate) (3200, scale bar
50 lm) and (D) Alizarin reaction shows calcium depositions within the calcification foci (3100, scale bar 100 lm). (E) Electron microscopy reveals a
lamellated structure of the calcifications with a very thin outer electron dense layer and some lighter concentric inner layers (31400, scale bar 10 lm).
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Fig. 4. Energy-filtered electron microscopy of a case with shell-like and globular calcifications of the phosphate type demonstrates the presence of (A)
calcium, (B) phosphor and (C) oxygen molecules within the shells of calcifications with the respective energy loss spectrum on the right.
Table 2. Proposed classification of nephrocalcinosis into calcium and phosphate typesa
Calcium type (associated with hypercalciuria) Phosphate type (associated with hyperphosphaturia)
With hyperphosphataemia With hyperphosphataemia
Tumor (osteolytic or humoral type) Sodium phosphate purgatives
Hyperparathyreoidism Children with nephrotic syndrome
Sarcoidosis and other granulomatous diseases
Vitamin D excess
Infantile hypercalcaemia
Without hypercalcaemia Without hyperphosphataemia
Idiopathic hypercalciuria Phosphate diabetes
Dent’s disease
Renal allografts Renal allografts
Hyperparathyreoidism Calcineurin inhibitor toxicity
aConditions and diseases likely associated with hypercalciuria (with or without hypercalcemia) and hyperphosphaturia (with or without hyperphospha-
temia) classified according to the expected type of calcification (calcium type with finely granular or clumpy calcifications and phosphate type with
globular or shell-like calcifications).
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some biopsies did not contain tissue of the renal medulla.
Thus, the distribution of the calcifications concerning cortex
or medulla in our study did not provide much information
about the possible cause.
Many of the calcifications seen in phosphate nephrop-
athy were localized within the tubular lumens. In contrast,
some of the calcium types of nephrocalcinosis had pre-
dominant interstitial calcifications. In our opinion, this
could rather reflect a time course, in which the initial phase
shows predominant intratubular calcifications and the later
stages have predominant interstitial calcifications. This
probably reflects a mechanism whereby larger calcium de-
posits destroy individual tubular cells and then move
through the basement membranes into the interstitial
space, which subsequently could cause interstitial fibrosis
(Figure 5). Since we do not know when precipitation of
calcium phosphate started in our cases, we cannot prove
the hypothesis in this study. However, the phenomenon of
migration of the calcifications from the tubular lumens
after epithelial overgrowth into the interstitium or the
so-called ‘exotubulosis’ was recently reported in animal
experiments [24]. They also depicted the morphological
phenomena outlined in Figure 5 in human renal biopsies.
Furthermore, smaller intratubular calcifications, which do
not affect the tubular epithelium, are most likely voided in
the urine.
In conclusion, simple light microscopy can distinguish a
calcium from a phosphate type of nephrocalcinosis, each
being associated with different diseases or conditions lead-
ing to calcification. Thus, histomorphology of nephrocalci-
nosis can help the clinician to assess the likely cause of
renal calcification.
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